Abstract

Glycoprotein (GP) IIb-IIIa antagonists appear to be associated with a modest increase in bleeding risk

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call